Stock Research for ARWR


Featured Broker: Ally Invest

Get the due diligence for another stock.


ARWR Stock Chart & Research Data

The ARWR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARWR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ARWR Due diligence Resources & Stock Charts

The ARWR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ARWR Detailed Price Forecast - CNN Money CNN View ARWR Detailed Summary - Google Finance
Yahoo View ARWR Detailed Summary - Yahoo! Finance Zacks View ARWR Stock Research & Analysis -

Stock Analysis

TradeIdeas View ARWR Trends & Analysis - Trade-Ideas Barrons View ARWR Major Holders - Barrons
NASDAQ View ARWR Call Transcripts - NASDAQ Seeking View ARWR Breaking News & Analysis - Seeking Alpha
Spotlight View ARWR Annual Report - OTC Report View ARWR OTC Short Report -
TradeKing View ARWR Fundamentals - TradeKing Charts View ARWR SEC Filings - Bar Chart
WSJ View Historical Prices for ARWR - The WSJ Morningstar View Performance/Total Return for ARWR - Morningstar
MarketWatch View the Analyst Estimates for ARWR - MarketWatch CNBC View the Earnings History for ARWR - CNBC
StockMarketWatch View the ARWR Earnings - StockMarketWatch MacroAxis View ARWR Buy or Sell Recommendations - MacroAxis
Bullish View the ARWR Bullish Patterns - American Bulls Short Pains View ARWR Short Pain Metrics -

Social Media Mentions

StockTwits View ARWR Stock Mentions - StockTwits PennyStocks View ARWR Stock Mentions - PennyStockTweets
Twitter View ARWR Stock Mentions - Twitter Invest Hub View ARWR Investment Forum News - Investor Hub
Yahoo View ARWR Stock Mentions - Yahoo! Message Board Seeking Alpha View ARWR Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ARWR - Insider Cow View Insider Transactions for ARWR - Insider Cow
CNBC View ARWR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ARWR - OTC Markets
Yahoo View Insider Transactions for ARWR - Yahoo! Finance NASDAQ View Institutional Holdings for ARWR - NASDAQ

Stock Charts

FinViz View ARWR Stock Insight & Charts - StockCharts View ARWR Investment Charts -
BarChart View ARWR Stock Overview & Charts - BarChart Trading View View ARWR User Generated Charts - Trading View

Latest Financial News for ARWR

Why Investors Are Paying a Premium for These 3 Biotech Stocks
Posted on Tuesday October 23, 2018

Here's how shares of these drugmakers surged to nosebleed valuations.

Market Trends Toward New Normal in IAC/InterActiveCorp, Eagle Pharmaceuticals, Arrowhead Pharmaceuticals, The Manitowoc, Brookdale Senior Living, and LATAM Airlines Group S.A — Emerging Consolidated Expectations, Analyst Ratings
Posted on Tuesday October 23, 2018

NEW YORK, Oct. 23, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

The Rally in Arrowhead Pharmaceuticals Has Been Impressive - Now What?
Posted on Friday October 19, 2018

In this daily bar chart of ARWR, below, we can see some strong price performance from December with prices rallying from $4 to touch $22 - impressive. The daily On-Balance-Volume (OBV) line shows an interesting rise from November to September. In this weekly bar chart of ARWR, below, we can see a parabolic rally from just $2 back in 2017 to $22 - one heck of a return.

Arrowhead Pharmaceuticals Hosts R&D Day on Pipeline of RNAi Therapeutics
Posted on Tuesday October 16, 2018

Arrowhead Pharmaceuticals Inc. (ARWR) is hosting a Research & Development (R&D) Day today in New York to discuss its emerging pipeline of RNAi therapeutics that leverage the Company’s proprietary Targeted RNAi Molecule (TRiM™) platform. In addition to senior members of the Arrowhead team, the R&D Day includes, Ira J. Goldberg, M.D., Bronfman Professor of Medicine, Chief of the Division of Endocrinology, Diabetes, and Metabolism, New York University Langone School of Medicine. A live and archived webcast of the event, with slides, may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.